Profund Advisors’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Profund Advisors's DFTX Position: Q3 2026 in Review
Profund Advisors increased its Definium Therapeutics (DFTX) stake by 216% in Q3 2026, buying an estimated $1.24M and bringing the position to 42,885 shares worth $1.63M. The position accounts for 0.05% of the portfolio, ranked #246.
Profund Advisors first reported a position in DFTX in Q3 2021 and has held it in 12 quarters since. 77 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Profund Advisors held 42,885 shares of Definium Therapeutics worth $1.63M as of Q3 2026.
- Profund Advisors bought 29,314 Definium Therapeutics shares in Q3 2026, an estimated $1.24M.
- Definium Therapeutics made up 0.05% of Profund Advisors's portfolio in Q3 2026, its #246 holding.
- Profund Advisors first reported a position in Definium Therapeutics in Q3 2021 and has held it in 12 quarters since.
- 77 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.